Correction to: IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 167(1): 407, 2018 01.
Article
in En
| MEDLINE
| ID: mdl-29071491
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2018
Type:
Article
Affiliation country:
United kingdom